Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Rong-hua Zhu"'
Autor:
Jian Li, Wen-qiang Wang, Rong-hua Zhu, Xing Lv, Jin-lin Wang, Bin-yong Liang, Er-lei Zhang, Zhi-yong Huang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe clinical value of postoperative adjuvant therapy (PAT) for hepatocellular carcinoma (HCC) remains unclear. This study aimed to explore the effect of PAT with tyrosine kinase inhibitors (TKIs) and anti-PD-1 antibodies on the surgical out
Externí odkaz:
https://doaj.org/article/f47c414af4fe4f8cac7caf52666a4c4f
Publikováno v:
Insight: Non-Destructive Testing & Condition Monitoring. Dec2022, Vol. 64 Issue 12, p702-708. 7p.
Autor:
Wen-qiang Wang, Jian Li, Bin-yong Liang, Xing Lv, Rong-hua Zhu, Jin-lin Wang, Zhi-yong Huang, Shu-hong Yang, Er-lei Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of
Externí odkaz:
https://doaj.org/article/35eceef12d154c81885bbefc3b7e14c1
Publikováno v:
Renewable Energy. 205:393-409
Publikováno v:
European Radiology. 33:4389-4400
We aimed to evaluate the efficacy of anti-programmed cell death 1 (PD-1)/programmed death-ligand 1 (PD-L1) antibody therapy by assessing the hyper-enhanced rim phenomenon of hepatocellular carcinoma (HCC) on Sonazoid-contrast-enhanced ultrasound (CEU
Publikováno v:
Journal of Civil Structural Health Monitoring. 13:67-81
Publikováno v:
Structures. 37:17-31
Publikováno v:
International Journal of Clinical Acupuncture; Sep2023, Vol. 32 Issue 3, p183-189, 7p
Autor:
Wen-Qiang Wang, Xing Lv, Jian Li, Jiang Li, Jin-Lin Wang, Tong Yuan, Jun-Jie Liu, Rong-Hua Zhu, Zhi-Yong Huang, Er-Lei Zhang
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
Repeat hepatectomy (RH) and microwave ablation (MWA) are frequently used procedures for the treatment of recurrent hepatocellular carcinoma (HCC) after curative resection. This study aimed to compare the long-term outcomes of RH and MWA for solitary
Autor:
Zhe Huang, Zhu Shu, Rong-Hua Zhu, Jun-Yi Xin, Ling-Ling Wu, Han-Zhang Wang, Jun Chen, Zhi-Wei Zhang, Hong-Chang Luo, Kai-Yan Li
Publikováno v:
World journal of gastrointestinal oncology. 14(12)
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy.To predict early recurrence (ER) and overall survival (OS) in patients with HCC after radical resection using deep learning-based radiomics (DLR).A total of 414 consecutive pa